top of page
backtmp6.jpg

UNLOCKING THE FULL
POTENTIAL OF CIRCULAR RNA 

Our science

RiboX focuses on the discovery and development of fully engineered circular RNA therapeutics - a new class of RNA medicines which can overcome current limitations of mRNA therapeutics and realize the full potential of RNA medicines.

background5.png

Executive Team

doctor1.png

Weiyi Zhang Ph.D.

Chief Executive Officer

WechatIMG100.jpg

Jennifer Kang Ph.D.

Head of IP & Corporate Legal

WechatIMG2520_edited_edited.jpg

Hariz Hassan M.D.

Head of Clinical Development & Medical Affairs

74fce917eb00c0e32f4631175e160f1590e570a39a26f391c1fad88c026c4603_edited.jpg

Siqi Li Ph.D.

Head of Molecular Engineering

Mengyao Zheng, Ph_edited.jpg

Mengyao Zheng Ph.D.

Head of CMC

output.jpg

Emma Pan, Ph.D.

Head of Research

4cdd4d5ed55dc573cbcbb4b088b477f22ffcff3df41e83e6e19a34a8f496555b.png

Roi Mashiach, Ph.D.

Head of Site (Israel)

Mengtao Xiao, , Ph.D..png

Mengtao Xiao Ph.D.

Head of Business Development

WechatIMG275.jpg

Mike Miao

Head of Business Operations

Email:

China

Global Headquarters

No. 15, Lane 388, Shengrong Road, Pudong New Area, Shanghai

200120 

© 2035 Powered and secured by RiboX

Israel

Beijing

Air China Plaza, No.40 Xiaoyun Road, Chaoyang District, Beijing 100027

Rehovot

Einstein 18, 4th floor, Ness Ziona

7403622

USA

Princeton

5 Vaughn Drive, Suite 308, New Jersey

08540

bottom of page